HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy

Several clinical trials have shown that oncolytic herpes simplex virus type 1 (oHSV-1) can be safely administered to patients. However, virus replication in tumor tissue has generally not been monitored in these oHSV clinical trials, and the data suggest that its oncolytic potency needs to be improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, H, Nakashima, H, Decklever, T D, Nace, R A, Russell, S J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747331/
https://www.ncbi.nlm.nih.gov/pubmed/23868101
http://dx.doi.org/10.1038/cgt.2013.43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747331/
https://www.ncbi.nlm.nih.gov/pubmed/23868101
http://dx.doi.org/10.1038/cgt.2013.43

Ejemplares similares